These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26060332)

  • 21. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
    Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M
    Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma proteome plus site-specific N-glycoprofiling for hepatobiliary carcinomas.
    Chang TT; Cheng JH; Tsai HW; Young KC; Hsieh SY; Ho CH
    J Pathol Clin Res; 2019 Jul; 5(3):199-212. PubMed ID: 31136099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
    Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of new biomarkers for cholangiocarcinoma.
    Miwa M; You G; Tanaka H; Taniguchi S; Fujii T; Kamemura K; Suzaki M; Isono T; Tooyama I; Tanaka M; Srivatanakul P; Viwatthanasittiphong C; Sangrajrang S; Khuhaprema T
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):397-8. PubMed ID: 24446393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases.
    Enjoji M; Yamaguchi K; Nakamuta M; Nakashima M; Kotoh K; Tanaka M; Nawata H; Watanabe T
    Dig Liver Dis; 2004 Sep; 36(9):622-7. PubMed ID: 15460847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.
    Amornpisutt R; Proungvitaya S; Jearanaikoon P; Limpaiboon T
    Tumour Biol; 2015 Jul; 36(7):4973-8. PubMed ID: 25652468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer.
    Christensen TD; Maag E; Larsen O; Feltoft CL; Nielsen KR; Jensen LH; Leerhøy B; Hansen CP; Chen IM; Nielsen DL; Johansen JS
    JHEP Rep; 2023 Mar; 5(3):100648. PubMed ID: 36699667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum metabolomics uncovering specific metabolite signatures of intra- and extrahepatic cholangiocarcinoma.
    Liang Q; Liu H; Zhang T; Jiang Y; Xing H; Zhang H
    Mol Biosyst; 2016 Feb; 12(2):334-40. PubMed ID: 26646623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
    Prakobwong S; Charoensuk L; Hiraku Y; Pinlaor P; Pairojkul C; Mairiang E; Sithithaworn P; Yongvanit P; Khuntikeo N; Pinlaor S
    Int J Cancer; 2012 Aug; 131(4):E416-24. PubMed ID: 21935919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma.
    Jamnongkan W; Lebrilla CB; Barboza M; Techasen A; Loilome W; Sithithaworn P; Khuntikeo N; Pairojkul C; Chamadol N; Thanan R; Yongvanit P
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G; Teli M; Jardine N; Puntis MC
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
    Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
    Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
    Koopmann J; Thuluvath PJ; Zahurak ML; Kristiansen TZ; Pandey A; Schulick R; Argani P; Hidalgo M; Iacobelli S; Goggins M; Maitra A
    Cancer; 2004 Oct; 101(7):1609-15. PubMed ID: 15378479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.
    Cheng Q; Feng F; Zhu L; Zheng Y; Luo X; Liu C; Yi B; Jiang X
    Sci Rep; 2015 Nov; 5():16103. PubMed ID: 26534789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
    Farina A; Dumonceau JM; Antinori P; Annessi-Ramseyer I; Frossard JL; Hochstrasser DF; Delhaye M; Lescuyer P
    Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.